Category

Daily Briefs

Most Read: Contemporary Amperex Technology (CATL), Fast Retailing, Guotai Junan Securities , Japfa Comfeed Indonesia, Sigma Healthcare, Indian Renewable Energy Development Agency, Areit (AyalaLand REIT), Sanyo Special Steel, Chuoh Pack Industry, Giga Prize and more

By | Daily Briefs, Most Read

In today’s briefing:

  • CATL (300750 CH): Index Inclusion Post H-Share Listing
  • Fast Retailing (9983 JP): Double Capping & The Reverse Funding Trade
  • Guotai Junan/Haitong Sec Merger: The Many Index Flows Around the Corner
  • IDX30/​​LQ45/IDX80 Index Rebalance: Big Impact in Some Stocks with 4 Days to Implementation
  • Sigma Healthcare (SIG AU): Shareholders Approve Merger; Passives Could Start Buying in Two Weeks
  • Indian Renewable Energy (IREDA IN) QIP: Index Implications
  • PCOMP Index Rebalance: AREIT, CBC to Replace NIKL, WLCON
  • Nippon Steal! Again. Parent Takes Out Sanyo Special Steel (5481) At Well Below Book
  • Nikkon Pays 273% Premium for Chuoh Pack (3952 JP) In Takeover
  • Freebit (3843) Buys Out Minorities in Giga Prize (3830) – Light, But Tough to Block


CATL (300750 CH): Index Inclusion Post H-Share Listing

By Brian Freitas


Fast Retailing (9983 JP): Double Capping & The Reverse Funding Trade

By Brian Freitas


Guotai Junan/Haitong Sec Merger: The Many Index Flows Around the Corner

By Brian Freitas


IDX30/​​LQ45/IDX80 Index Rebalance: Big Impact in Some Stocks with 4 Days to Implementation

By Brian Freitas


Sigma Healthcare (SIG AU): Shareholders Approve Merger; Passives Could Start Buying in Two Weeks

By Brian Freitas

  • Sigma Healthcare (SIG AU) and Chemist Warehouse (CWG) shareholders have approved the merger with 99.86% and 100% of the votes cast in favour.
  • The Second Court Hearing is on 3 February and the merger will be implemented on 12 February, which is when the passive buying could commence.
  • Sigma Healthcare has continued to trade higher on a record margin and sales expansion for CWG and expected passive buying that could top A$3bn over the next few months.

Indian Renewable Energy (IREDA IN) QIP: Index Implications

By Brian Freitas

  • IREDA has announced a Qualified Institutional Placement (QIP) of a maximum of INR 50bn as long as the Government of India’s holding does not drop by more than 7%.
  • There will be passive buying at the time of settlement of the QIP shares while the increase in float will bring the stock closer to inclusion in another global index.
  • With the stock close to index inclusion level and down 37% from its peak, there could be positioning in the stock for passive inflows.

PCOMP Index Rebalance: AREIT, CBC to Replace NIKL, WLCON

By Brian Freitas


Nippon Steal! Again. Parent Takes Out Sanyo Special Steel (5481) At Well Below Book

By Travis Lundy

  • 6-7 years ago Sanyo Special Steel (5481 JP) bought out a large foreign specialty steel company, and funded it by getting Nippon Steel to inject capital at below book. 
  • Now Nippon Steel is buying the rest of Sanyo Special Steel in a Tender Offer at 0.66x book, where most of book is Net Receivables, Inventory, WIP, and Materials.
  • This is the second time in a decade where the Board has decided to sell control of itself at far below book value. They should be ashamed of themselves.

Nikkon Pays 273% Premium for Chuoh Pack (3952 JP) In Takeover

By Travis Lundy

  • Today, Nikkon Holdings (9072 JP) announced it would take over Chuoh Pack Industry (3952 JP) for ¥5,034/share. It closed today at ¥1,349. This is a HUGE win for governance.
  • The 273% premium is not the big win here. For holders it is, of course, but for Japan Inc shareholders everywhere, the win was the auction process. 
  • This could have come out at 100% premium and that might have been OK. As it is, cross-holders and one big holder together get this deal done. Congrats!

Freebit (3843) Buys Out Minorities in Giga Prize (3830) – Light, But Tough to Block

By Travis Lundy

  • Today, Freebit Co Ltd (3843 JP) announced it would launch a Tender Offer next Monday to buy out minorities in 60.9%-owned Giga Prize (3830 JP)
  • The multiple is not terribly impressive. It could be better. But they only need 5.8% of the 39.1% they do not own to get this over the hump.
  • Synergies are clear. They are expected. They are not priced in the valuation. This is disappointing. Again.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Analytics and News
  • ✓ Events & Webinars



Daily Brief Consumer: Fast Retailing, Tesla and more

By | Consumer, Daily Briefs

In today’s briefing:

  • Last Week in Event SPACE: Fast Retailing, Sigma, Takeda Pharmaceutical, WH Group
  • Tesla’s Growth Story Facing Challenges Amidst Optimism for AI and Autonomy?


Last Week in Event SPACE: Fast Retailing, Sigma, Takeda Pharmaceutical, WH Group

By David Blennerhassett

  • It was confirmed on Friday afternoon Fast Retailing (9983 JP) was a single cap move, NOT a double-capping in a single Review. That limits the sell down.
  • Chemist Warehouse’s reverse buyout of pharmacy wholesaler Sigma Healthcare (SIG AU) is now all-but complete.
  • Takeda Pharmaceutical (4502 JP) announced decent results, decently upgraded guidance in both IFRS/GAAP terms and in Core/Adjusted terms (less impressive uplift in Adjusted/Analysed terms). They also announced a ¥100bn buyback.

Tesla’s Growth Story Facing Challenges Amidst Optimism for AI and Autonomy?

By Baptista Research

  • Tesla’s fourth-quarter earnings highlighted a company at the crossroads of transformation and challenge.
  • Despite achieving a record market valuation of $1.5 trillion in December, the company’s core automotive business struggled, with an 8% year-over-year revenue decline.
  • Demand softened, particularly for the Cybertruck, forcing Tesla to rely on aggressive promotional strategies to sustain sales.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Top 10 Highlights from the APAC PE, VC and Startup Ecosystem this Week – 02 Feb 2025

By | Private Markets, Smartkarma Newswire

Top ten highlights from the APAC PE, VC, and startup ecosystem this week:

  1. DeepSeek, a Chinese startup, emerges as a potential rival to OpenAI, shaking up the tech markets with its efficient AI models using fewer resources.
  2. Silicon Valley investors praise DeepSeek’s AI breakthrough, while American tech rivals raise concerns about intellectual property issues.
  3. AI-focused ventures in Asia anticipate the impact of DeepSeek’s innovation on investment needs and market trends.
  4. Startups in Southeast Asia face fundraising challenges, with a historic low of $4.56 billion in equity funding in 2024.
  5. Fintech businesses shine amid the funding downturn, with over a third of total fundraising value coming from the sector.
  6. Indonesian aquatech startup eFishery faces uncertainty following fraud allegations, raising questions about its future.
  7. Vietnam’s Telio closes down despite recent funding, signaling challenges in the startup ecosystem.
  8. Indian expansion plans of eFishery hit obstacles, sparking concerns about governance in the startup landscape.
  9. Indian PE-VC sector prepares for a tough fundraising season amidst market volatility and shifting investment strategies.
  10. Meesho, an Indian e-commerce platform, secures $550 million funding at a reduced valuation, reflecting market pressures and investor sentiment.

APAC Private Markets Research

Explore latest Insights on APAC Private Markets on Smartkarma


Disclaimer:This article by is general in nature and based on publicly available information and not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material. While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.


 

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Analytics and News
  • ✓ Events & Webinars

Also, check out the latest in ECM Research on Smartkarma